Kerry A. Rogers, MD

Kerry A. Rogers, MD, is an associate professor with tenure in the Division of Hematology at The Ohio State University, specializing in chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL).

She earned her bachelor of arts degree from Northwestern University and her medical degree from Chicago Medical School. She completed her residency in internal medicine at the University of Michigan and her fellowship in hematology and medical oncology at The Ohio State University, where she is currently a faculty member.

Dr Rogers is an expert in caring for patients with CLL and HCL in the clinic. In addition to expert patient care, she conducts both clinical and translational laboratory work on BTK inhibitor combination regimens for the treatment of CLL utilizing currently approved and novel agents. She is also a part of the active HCL research community. Her other interests include complications of targeted therapy for CLL, the management of Richter’s transformation, and primary and CLL-associated autoimmune cytopenias.